Eli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy. Patients with a body mass index of at least 35 and at least...